Clinical Trials
676
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (554 trials with phase data)• Click on a phase to view related trials
Postcards to Improve Remote Monitoring Adherence Among Veterans
- Conditions
- Adherence, PatientICDPacemaker DDD
- First Posted Date
- 2023-10-05
- Last Posted Date
- 2023-10-05
- Lead Sponsor
- US Department of Veterans Affairs
- Target Recruit Count
- 6351
- Registration Number
- NCT06068699
- Locations
- 🇺🇸
San Francisco VA Medical Center, San Francisco, California, United States
Groups for Regaining Our Wellbeing (GROW)
- Conditions
- Posttraumatic Stress DisorderDepression
- First Posted Date
- 2013-10-29
- Last Posted Date
- 2014-07-02
- Lead Sponsor
- US Department of Veterans Affairs
- Registration Number
- NCT01971541
- Locations
- 🇺🇸
VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington, United States
Comparison of the Effect of Intense-Exercise/Moderate-Calorie, Topiramate-Phentermine and Cognitive Behavioral Therapy on Obesity
- Conditions
- ObesityDiabetes Mellitus
- First Posted Date
- 2013-10-28
- Last Posted Date
- 2014-01-15
- Lead Sponsor
- US Department of Veterans Affairs
- Registration Number
- NCT01970566
- Locations
- 🇺🇸
Captain James A. Lovell Federal Health Care Center, North Chicago, IL, North Chicago, Illinois, United States
Telehealth Self Management for CHF
- Conditions
- Heart Failure
- First Posted Date
- 2013-03-18
- Last Posted Date
- 2014-12-02
- Lead Sponsor
- US Department of Veterans Affairs
- Registration Number
- NCT01812512
- Locations
- 🇺🇸
Ralph H Johnson VA Medical Center, Charleston, South Carolina, United States
🇺🇸Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC, Columbia, South Carolina, United States
IMproving Pain Using Peer RE-inforced Self-management Skills
- Conditions
- Chronic Pain
- First Posted Date
- 2012-12-12
- Last Posted Date
- 2015-05-15
- Lead Sponsor
- US Department of Veterans Affairs
- Target Recruit Count
- 20
- Registration Number
- NCT01748227
- Locations
- 🇺🇸
Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis, Indiana, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 136
- Next
News
HOPE Therapeutics Receives Florida Regulatory Approval for Dura Medical Acquisition to Expand Precision Psychiatry Network
HOPE Therapeutics, a subsidiary of NRx Pharmaceuticals, received final clearance from Florida's Agency for Health Care Administration to proceed with the acquisition of Dura Medical LLC, a revenue-generating and EBITDA-positive precision psychiatry clinic network.
Study Shows DAA Therapy Matches Interferon in Reducing Liver Cancer Risk for HCV Patients
• A large VA healthcare system study reveals that direct-acting antiviral (DAA) therapy significantly reduces hepatocellular carcinoma risk compared to no treatment in HCV patients with cirrhosis. • The research demonstrates comparable hepatocellular carcinoma risk reduction between DAA therapy and historical interferon treatments, with DAA achieving superior cure rates of over 95%. • Among study participants, 89.39% of DAA-treated patients achieved sustained virologic response, compared to 36.55% in the interferon-treated group, supporting DAA's favorable risk-benefit profile.